Advances in genomic characterization of circulating tumor cells

Cancer and Metastasis Reviews

Volumn 33, Issue 2-3, 2014, Pages 757-769

  Magbanua, Mark Jesus M ^a   Park, John W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circulating tumor cells; Copy number; Enrichment; Gene expression; Genomics; Isolation; Molecular characterization

Indexed keywords

BIOLOGICAL MARKER; DNA; NUCLEIC ACID; RNA;

ANALYTIC METHOD; CELL ISOLATION; CIRCULATING TUMOR CELL; COPY NUMBER VARIATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE EXPRESSION; GENOMICS; HUMAN; IMMUNOMAGNETIC SEPARATION; MICROFLUIDICS; MICROMANIPULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; CELL SEPARATION; GENE EXPRESSION PROFILING; GENETICS; META ANALYSIS; NEOPLASM; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

CELL SEPARATION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84905125915     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-014-9503-7     Document Type: Review

References (71)

1. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews Cancer, 9(4), 302-312.
2. Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008). Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nature Reviews Cancer, 8(5), 329-340. (Pubitemid 351596394)
3. Alix-Panabieres, C., & Pantel, K. (2013). Circulating tumor cells: liquid biopsy of cancer. Clinical Chemistry, 59(1), 110-118.
4. Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., et al. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical Cancer Research, 10(20), 6897-6904. (Pubitemid 39383039)
5. Cohen, S. J., Punt, C. J., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., et al. (2009). Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of Oncology, 20(7), 1223-1229.
6. Connelly, M., Wang, Y., Doyle, G. V., Terstappen, L., & McCormack, R. (2009). Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Journal of the National Cancer Institute, 101(12), 895. author reply 896-897.
7. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. New England Journal of Medicine, 351(8), 781-791. (Pubitemid 39095313)
8. Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., et al. (2005). Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Journal of Clinical Oncology, 23(7), 1420-1430.
9. de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., et al. (2008). Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clinical Cancer Research, 14(19), 6302-6309.
10. Danila, D. C., Fleisher, M., & Scher, H. I. (2011). Circulating tumor cells as biomarkers in prostate cancer. Clinical Cancer Research, 17(12), 3903-3912.
11. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., et al. (1998). High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genetics, 20(2), 207-211. (Pubitemid 28455458)
12. Cohen, S. J., Punt, C. J., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., et al. (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 26(19), 3213-3221.
13. Sieuwerts, A. M., Kraan, J., Bolt-de Vries, J., van der Spoel, P., Mostert, B., Martens, J. W., et al. (2009). Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Research and Treatment, 118(3), 455-468.
14. Talasaz, A.H., Powell, A. A., Huber, D. E., Berbee, J. G., Roh, K.H., Yu, W., et al. (2009). Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proceedings of the National Academy of Sciences of the United States of America, 106(10), 3970-3975.
15. Ramskold, D., Luo, S., Wang, Y. C., Li, R., Deng, Q., Faridani, O. R., et al. (2012). Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nature Biotechnology, 30(8), 777-782.
16. Barbazan, J., Alonso-Alconada, L., Muinelo-Romay, L., Vieito, M., Abalo, A., Alonso-Nocelo, M., et al. (2012). Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PLoS One, 7(7), e40476.
17. Stott, S. L., Hsu, C. H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., et al. (2010). Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proceedings of the National Academy of Sciences of the United States of America, 107(43), 18392-18397.
18. Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., et al. (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 450(7173), 1235-1239.
19. Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E., et al. (2013). Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Science Translational Medicine, 5(179), 179ra147.
20. Desitter, I., Guerrouahen, B. S., Benali-Furet, N., Wechsler, J., Janne, P.A., Kuang, Y., et al. (2011). A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Research, 31(2), 427-441.
21. Lu, J., Fan, T., Zhao, Q., Zeng, W., Zaslavsky, E., Chen, J. J., et al. (2010). Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype frombreast cancer patients. International Journal of Cancer, 126(3), 669-683.
22. Paris, P. L., Kobayashi, Y., Zhao, Q., Zeng, W., Sridharan, S., Fan, T., et al. (2009). Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Letters, 277(2), 164-173.
23. Yamada, K. M., & Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell, 130(4), 601-610. (Pubitemid 47268064)
24. Magbanua, M. J., & Park, J.W. (2013). Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling. Methods, 64(2), 114-118.
25. Mathiesen, R. R., Fjelldal, R., Liestol, K., Due, E. U., Geigl, J. B., Riethdorf, S., et al. (2012). High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. International Journal of Cancer, 131(4), E405-E415.
26. Tan, S. C., & Yiap, B. C. (2009). DNA, RNA, and protein extraction: the past and the present. Journal of Biomedicine and Biotechnology, 2009, 574398.
27. Xu, C., Houck, J. R., Fan, W., Wang, P., Chen, Y., Upton, M., et al. (2008). Simultaneous isolation of DNA and RNA from the same cell population obtained by laser capture microdissection for genome and transcriptome profiling. Journal of Molecular Diagnostics, 10(2), 129-134. (Pubitemid 351428394)
28. Sieuwerts, A. M., & Jeffrey, S. S. (2012). Multiplex molecular analysis of CTCs. Recent Results in Cancer Research, 195, 125-140.
29. Macarthur, D. (2012). Methods: face up to false positives. Nature, 487(7408), 427-428.
30. Smirnov, D. A., Zweitzig, D. R., Foulk, B.W., Miller, M. C., Doyle, G. V., Pienta, K. J., et al. (2005). Global gene expression profiling of circulating tumor cells. Cancer Research, 65(12), 4993-4997. (Pubitemid 40827303)
31. O'Hara, S.M., Moreno, J. G., Zweitzig, D. R., Gross, S., Gomella, L. G.,& Terstappen, L.W. (2004). Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clinical Chemistry, 50(5), 826-835. (Pubitemid 38543661)
32. Sieuwerts, A.M., Mostert, B., Bolt-de Vries, J., Peeters, D., de Jongh, F. E., Stouthard, J. M., et al. (2011). mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clinical Cancer Research, 17(11), 3600-3618.
33. Powell, A. A., Talasaz, A. H., Zhang, H., Coram, M. A., Reddy, A., Deng, G., et al. (2012). Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One, 7(5), e33788.
34. Tang, A., Eller, M. S., Hara, M., Yaar, M., Hirohashi, S., & Gilchrest, B. A. (1994). E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. Journal of Cell Science, 107(Pt 4), 983-992. (Pubitemid 24119356)
35. Cann, G.M., Gulzar, Z. G., Cooper, S., Li, R., Luo, S., Tat, M., et al. (2012). mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One, 7(11), e49144.
36. Yu, M., Ting, D. T., Stott, S. L., Wittner, B. S., Ozsolak, F., Paul, S., et al. (2012). RNA sequencing of pancreatic circulating tumour cells implicates WNTsignalling in metastasis. Nature, 487(7408), 510-513.
37. Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339(6119), 580-584.
38. Miyamoto, D. T., Lee, R. J., Stott, S. L., Ting, D. T., Wittner, B. S., Ulman, M., et al. (2012). Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discovery, 2(11), 995-1003.
39. Chen, C. L., Mahalingam, D., Osmulski, P., Jadhav, R. R., Wang, C. M., Leach, R. J., et al. (2013). Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMTrelated genes in metastatic prostate cancer. Prostate, 73(8), 813-826.
40. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
41. Klein, C. A., Schmidt-Kittler, O., Schardt, J. A., Pantel, K., Speicher, M. R., & Riethmuller, G. (1999). Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proceedings of the National Academy of Sciences of the United States of America, 96(8), 4494-4499. (Pubitemid 29190364)
42. Schmidt-Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J., et al. (2003). From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America, 100(13), 7737-7742. (Pubitemid 36760039)
43. Schardt, J. A., Meyer, M., Hartmann, C. H., Schubert, F., Schmidt-Kittler, O., Fuhrmann, C., et al. (2005). Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell, 8(3), 227-239. (Pubitemid 41317593)
44. Fuhrmann, C., Schmidt-Kittler, O., Stoecklein, N. H., Petat-Dutter, K., Vay, C., Bockler, K., et al. (2008). High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Research, 36(7), e39.
45. Holcomb, I. N., Grove, D. I., Kinnunen, M., Friedman, C. L., Gallaher, I. S., Morgan, T. M., et al. (2008). Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Research, 68 (14), 5599-5608.
46. Weckermann, D., Polzer, B., Ragg, T., Blana, A., Schlimok, G., Arnholdt, H., et al. (2009). Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. Journal of Clinical Oncology, 27(10), 1549-1556.
47. Pierga, J. Y., Bonneton, C., Vincent-Salomon, A., de Cremoux, P., Nos, C., Blin, N., et al. (2004). Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clinical Cancer Research, 10(4), 1392-1400. (Pubitemid 38365234)
48. Muller, V., Stahmann, N., Riethdorf, S., Rau, T., Zabel, T., Goetz, A., et al. (2005). Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clinical Cancer Research, 11(10), 3678-3685. (Pubitemid 40685584)
49. Wiedswang, G., Borgen, E., Schirmer, C., Karesen, R., Kvalheim, G., Nesland, J. M., et al. (2006). Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. International Journal of Cancer, 118(8), 2013-2019.
50. Magbanua, M. J., Sosa, E. V., Roy, R., Eisenbud, L. E., Scott, J. H., Olshen, A., et al. (2013). Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Research, 73(1), 30-40.
51. Magbanua, M. J., Sosa, E. V., Scott, J. H., Simko, J., Collins, C., Pinkel, D., et al. (2012). Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer, 12(1), 78.
52. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C., et al. (1995). In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genetics, 9(4), 401-406.
53. Hannemann, J., Meyer-Staeckling, S., Kemming, D., Alpers, I., Joosse, S. A., Pospisil, H., et al. (2011). Quantitative high-resolution genomic analysis of single cancer cells. PLoS One, 6(11), e26362.
54. Ulmer, A., Schmidt-Kittler, O., Fischer, J., Ellwanger, U., Rassner, G., Riethmuller, G., et al. (2004). Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clinical Cancer Research, 10(2), 531-537. (Pubitemid 38173991)
55. Heitzer, E., Auer, M., Gasch, C., Pichler, M., Ulz, P., Hoffmann, E. M., et al. (2013). Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Research, 73(10), 2965-2975.
56. Ni, X., Zhuo, M., Su, Z., Duan, J., Gao, Y., Wang, Z., et al. (2013). Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America, 110 (52), 21083-21088.
57. Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012). Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science, 338(6114), 1622-1626.
58. Chambers, A. F., Naumov, G. N., Vantyghem, S. A., & Tuck, A. B. (2000). Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Research, 2(6), 400-407. (Pubitemid 32223636)
59. Cameron, M. D., Schmidt, E. E., Kerkvliet, N., Nadkarni, K. V., Morris, V. L., Groom, A. C., et al. (2000). Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Research, 60(9), 2541-2546. (Pubitemid 30262450)
60. Wong, C. W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., et al. (2001). Apoptosis: an early event in metastatic inefficiency. Cancer Research, 61(1), 333-338. (Pubitemid 32095735)
61. Baccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., et al. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nature Biotechnology, 31(6), 539-544.
62. Wan, L., Pantel, K., & Kang, Y. (2013). Tumor metastasis: moving new biological insights into the clinic. Nature Medicine, 19(11), 1450-1464.
63. Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L., et al. (2009). Tumor self-seeding by circulating cancer cells. Cell, 139(7), 1315-1326.
64. Steinert, G., Scholch, S., Niemietz, T., Iwata, N., Garcia, S. A., Behrens, B., et al. (2014). Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Research, 74(6), 1694-1704.
65. Howard, E. W., Leung, S. C., Yuen, H. F., Chua, C. W., Lee, D. T., Chan, K. W., et al. (2008). Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clinical & Experimental Metastasis, 25(5), 497-508.
66. Bednarz-Knoll, N., Alix-Panabieres, C.,& Pantel, K. (2011). Clinical relevance and biology of circulating tumor cells. Breast Cancer Research, 13(6), 228.
67. Gray, J.W. (2003). Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell, 4(1), 4-6.
68. Park, J. W. (2011). Disseminated tumor cells: the method is the message. Breast Cancer Research and Treatment, 125(3), 739-740.
69. Plaks, V., Koopman, C. D., & Werb, Z. (2013). Cancer, Circulating tumor cells. Science, 341(6151), 1186-1188.
70. Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M., et al. (2009). Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Journal of the National Cancer Institute, 101(1), 61-66.
71. Wang, D., & Bodovitz, S. (2010). Single cell analysis: the new frontier in 'omics'. Trends in Biotechnology, 28(6), 281-290.